Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents
出版年份 2023 全文链接
标题
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents
作者
关键词
-
出版物
Expert Review of Anti-Infective Therapy
Volume -, Issue -, Pages 1-17
出版商
Informa UK Limited
发表日期
2023-10-25
DOI
10.1080/14787210.2023.2275663
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring
- (2023) Cindy Lau et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- PK/PD parameters of linezolid in the epithelial lining fluid of patients with sepsis
- (2022) Changde Wu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
- (2022) Christopher JL Murray et al. LANCET
- Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
- (2022) Thomas P Lodise et al. Open Forum Infectious Diseases
- Population pharmacokinetics and toxicodynamics of continuously infused linezolid in critically ill patients
- (2022) Sebastian G. Wicha et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial
- (2022) Nicholas A. Turner et al. Trials
- The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe
- (2022) Steven Y C Tong et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetic Modeling and Probability of Target Attainment of Ceftaroline in Brain and Soft Tissues
- (2022) Victória Etges Helfer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- LB2302. Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE)
- (2022) Thomas L Holland et al. Open Forum Infectious Diseases
- Association of Linezolid With Risk of Serotonin Syndrome in Patients Receiving Antidepressants
- (2022) Anthony D. Bai et al. JAMA Network Open
- Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus
- (2021) Hideo Kato et al. Journal of Global Antimicrobial Resistance
- Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis
- (2021) Alberto Enrico Maraolo et al. Antibiotics-Basel
- Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021
- (2021) Laura Evans et al. CRITICAL CARE MEDICINE
- Linezolid for infective endocarditis
- (2021) P. Muñoz et al. MEDICINE
- Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia
- (2020) Steven Y. C. Tong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
- (2020) Michael J Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention
- (2020) Gwendolyn M. Pais et al. PHARMACOTHERAPY
- Antimicrobial Use in US Hospitals: Comparison of Results From Emerging Infections Program Prevalence Surveys, 2015 and 2011
- (2020) Shelley S Magill et al. CLINICAL INFECTIOUS DISEASES
- Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study
- (2020) Richard Kuehl et al. LANCET INFECTIOUS DISEASES
- Linezolid for therapy of Staphylococcus aureus meningitis: a cohort study of 26 patients
- (2020) Vicente Pintado et al. Infectious Diseases
- Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan
- (2020) Hong-An Chen et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis
- (2019) S. Piva et al. Neurocritical Care
- Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States
- (2019) Athena P. Kourtis et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Vancomycin Area under the Curve and Acute Kidney Injury: A Meta-analysis
- (2019) Doaa M Aljefri et al. CLINICAL INFECTIOUS DISEASES
- Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2019) Matthew Geriak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Defining the Breakpoint Duration of Staphylococcus aureus Bacteremia Predictive of Poor Outcomes
- (2019) Emi Minejima et al. CLINICAL INFECTIOUS DISEASES
- On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
- (2019) Taylor Morrisette et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study
- (2019) Maria Souli et al. CLINICAL INFECTIOUS DISEASES
- The Emperor’s New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)
- (2019) Thomas P Lodise et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Adverse Drug Reactions Between Patients Treated With Ceftaroline or Ceftriaxone: A Single-Center, Matched Cohort Study
- (2019) Jeffrey W Jansen et al. Open Forum Infectious Diseases
- Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
- (2019) Joshua P. Metlay et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study
- (2019) Sarah C J Jorgensen et al. CLINICAL INFECTIOUS DISEASES
- Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report
- (2019) Aaron Hakim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
- (2019) Erin K McCreary et al. Open Forum Infectious Diseases
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies
- (2018) J. Nicholas O'Donnell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftaroline for Suspected or Confirmed Invasive Methicillin-Resistant Staphylococcus aureus
- (2018) Jeffrey J. Cies et al. Pediatric Critical Care Medicine
- Risk factors for linezolid-induced thrombocytopenia in patients without haemato-oncologic diseases
- (2018) Go Wun Choi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections
- (2018) Shampa Das et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections
- (2018) Adèle Sakr et al. Frontiers in Microbiology
- Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies
- (2017) Pier Giorgio Cojutti et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin-Associated Cast Nephropathy
- (2017) Yosu Luque et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
- (2016) Kimberly C. Claeys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects
- (2016) Todd A. Riccobene et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats
- (2016) Nathaniel J. Rhodes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients
- (2016) Antonio D’Avolio et al. DRUGS
- Adverse Drug Reactions Associated with Ceftaroline Use: A 2-Center Retrospective Cohort
- (2016) Kimberly G. Blumenthal et al. Journal of Allergy and Clinical Immunology-In Practice
- Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations
- (2015) Sujata M. Bhavnani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Ceftaroline in Normal Body Weight and Obese (Classes I, II, and III) Healthy Adult Subjects
- (2015) Julie Ann Justo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Association between Vancomycin Day 1 Exposure Profile and Outcomes among Patients with Methicillin-Resistant Staphylococcus aureus Infective Endocarditis
- (2015) Anthony M. Casapao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
- (2015) Larry M. Baddour et al. CIRCULATION
- Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-SusceptibleStaphylococcus aureusBloodstream Infections Among 122 Hospitals
- (2015) Jennifer S. McDanel et al. CLINICAL INFECTIOUS DISEASES
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
- (2015) Steven Y. C. Tong et al. CLINICAL MICROBIOLOGY REVIEWS
- Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial
- (2015) Nan Shan Zhong et al. LANCET INFECTIOUS DISEASES
- Ceftobiprole for the treatment of pneumonia: a European perspective
- (2015) Antoni Torres et al. Drug Design Development and Therapy
- Innovative approaches to optimizing the delivery of vancomycin in individual patients
- (2014) Manjunath P. Pai et al. ADVANCED DRUG DELIVERY REVIEWS
- A case of profound neutropenia and agranulocytosis associated with off-label use of ceftaroline
- (2014) F. K. Yam et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies
- (2014) Steven L Barriere et al. BMC INFECTIOUS DISEASES
- Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?
- (2014) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching Therapy
- (2014) R. Kullar et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2014) Abhay Dhand et al. CLINICAL THERAPEUTICS
- Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis
- (2014) Yan Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials
- (2014) W. He et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftaroline CSF concentrations in a patient with ventriculoperitoneal shunt-related meningitis
- (2014) S. S. Kuriakose et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Successful use of ceftaroline for the treatment of MRSA meningitis secondary to an infectious complication of lumbar spine surgery
- (2014) M. A. Balouch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid Penetration Into Cerebrospinal Fluid and Brain Tissue
- (2014) A. Tsona et al. JOURNAL OF CHEMOTHERAPY
- Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience
- (2014) Ananthakrishnan Ramani et al. JOURNAL OF CHEMOTHERAPY
- High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline
- (2014) Rupali Jain et al. PHARMACOTHERAPY
- Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy
- (2013) John Bucheit et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
- (2013) Natasha E. Holmes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?
- (2013) Michael N. Neely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Considerations for Higher Doses of Daptomycin in Critically Ill Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
- (2013) Marco Falcone et al. CLINICAL INFECTIOUS DISEASES
- Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study
- (2013) Kyle P. Murray et al. CLINICAL INFECTIOUS DISEASES
- A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis
- (2013) Kristen M. Gawronski et al. CLINICAL THERAPEUTICS
- Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the “seesaw effect”: Taking advantage of the back door left open?
- (2013) Jessica K. Ortwine et al. DRUG RESISTANCE UPDATES
- Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial
- (2013) Alexander Konychev et al. DRUGS & AGING
- Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials
- (2013) H. Jiang et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Area under the concentration–time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia
- (2013) Younghee Jung et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftaroline - a cause for neutropenia
- (2013) R. H. Rimawi et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Vancomycin versus Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Meningitis
- (2013) Oguz Resat Sipahi et al. Surgical Infections
- Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis
- (2013) Andre C Kalil et al. BMJ Open
- The Relationship of Nephrotoxicity to Vancomycin Trough Serum Concentrations in a Veteran's Population: A Retrospective Analysis
- (2012) Amy Horey et al. ANNALS OF PHARMACOTHERAPY
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
- (2012) S. J. van Hal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Pharmacokinetics and Pharmacodynamics in a Pooled Sample of Patients Receiving Thrice-Weekly Hemodialysis
- (2012) J. M. Butterfield et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Controlled Trial of the Safety and Efficacy of Daptomycin versus Standard-of-Care Therapy for Management of Patients with Osteomyelitis Associated with Prosthetic Devices Undergoing Two-Stage Revision Arthroplasty
- (2012) Ivor Byren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Staphylococcus aureus Bacteremia
- (2012) S. J. van Hal et al. CLINICAL MICROBIOLOGY REVIEWS
- Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP Database
- (2012) Ennie L. Cano et al. CLINICAL THERAPEUTICS
- Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy
- (2012) T. T. Ho et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients
- (2012) F. Pea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections
- (2012) Naoki Aikawa et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Anti-Infectious Agents against MRSA
- (2012) Nobuhiro Koyama et al. MOLECULES
- Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
- (2011) Jack Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
- (2011) Marin L Schweizer et al. BMC INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections
- (2011) S.R. Quist et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Linezolid for endocarditis: a case series of 14 patients
- (2011) C. Tascini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia
- (2011) Donald E. Low et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid pharmacokinetics and pharmacodynamics in clinical treatment
- (2011) M. S. Dryden JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Ceftaroline against Community-Associated Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Daptomycin-Nonsusceptible Staphylococcus aureus Isolates
- (2010) L. Saravolatz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection
- (2010) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia
- (2010) Thomas M. File et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis
- (2010) A. Mary Vilay et al. CRITICAL CARE MEDICINE
- In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates
- (2010) Céline Vidaillac et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
- (2010) M. H. Wilcox et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
- (2010) G. R. Corey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Linezolid Treatment for Intracranial Abscesses Caused by Methicillin-Resistant Staphylococcus Aureus
- (2010) Norihiko SAITO et al. NEUROLOGIA MEDICO-CHIRURGICA
- Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
- (2009) Pamela A Moise et al. ANNALS OF PHARMACOTHERAPY
- Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized Patients
- (2009) Thomas P. Lodise et al. CLINICAL INFECTIOUS DISEASES
- Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
- (2009) Joseph S. Solomkin et al. CLINICAL INFECTIOUS DISEASES
- The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas
- (2009) P. E. Pertel et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2008) W. E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States
- (2008) Y. Ge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria
- (2008) D. E. Katz et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search